Top in rheumatology: Pediatric fellowships, respiratory tract diseases and RA risk
Click Here to Manage Email Alerts
According to data released by the National Resident Matching Program, less than 70% of pediatric rheumatology fellowship programs were filled for the 2022 appointment year.
The data underscore the need to increase interest in pediatric rheumatology as the subspecialty is already experiencing a dire workforce shortage, the American College of Rheumatology said in a press release. It was the top story in rheumatology last week.
Another top story was about a study that showed sinusitis, acute respiratory tract burden and pharyngitis may increase the risk for rheumatoid arthritis.
Read these and more top stories in rheumatology below:
Pediatric rheumatology comes up short on Match Day: Just 69% of fellowship slots filled
Results from the 2021 Medical Specialties Matching Program reveal that pediatric rheumatology fellowship programs filled less than 70% of their available slots, according to the American College of Rheumatology. Read more.
Sinusitis, ‘common cold’ may increase risk for developing rheumatoid arthritis
Sinusitis, acute respiratory tract burden and even pharyngitis — also known as the common cold — are potential risk factors for rheumatoid arthritis, according to data published in The Journal of Rheumatology. Read more.
Upadacitinib effective as monotherapy, in combination with non-biologics for PsA
Upadacitinib demonstrates comparable efficacy and safety as monotherapy or in combination with non-biologic disease-modifying antirheumatic drugs in patients with psoriatic arthritis, according to data published in Rheumatology. Read more.
Coherus’ Yusimry nabs FDA approval as seventh Humira biosimilar in cramped market
The FDA has approved the seventh biosimilar to adalimumab, Yusimry (adalimumab-aqvh, Coherus BioSciences), for all eligible indications of the biologic product, the latest in an increasingly crowded biosimilar logjam set to release in 2023. Read more.
Elevated spine symptoms in psoriatic arthritis linked to worse quality of life, disease activity
Patients with self-reported elevated spine symptoms in psoriatic arthritis, with or without a diagnosis of axial disease, had worse quality of life and disease activity overall versus patients without axial manifestations, according to data. Read more.